| ¿µ¹® | teratoma | ÇÑ±Û | ±âÇüÁ¾ |
|---|---|---|---|
| ¼³¸í | Çϳª ÀÌ»óÀÇ ¹è¿±(germ layer)¿¡¼ ±â¿øÇÑ ¼¼Æ÷·Î Çü¼ºµÈ Á¾¾ç. ÀϹÝÀûÀ¸·Î ¼º»ùÀÇ ÀüÇü¹ßÀ°¼¼Æ÷(totipotent cell)¿¡¼ À¯·¡ÇÑ´Ù. º´¸®Á¶Á÷ÇÐÀûÀ¸·Î ¼º¼÷, ¹Ì¼º¼÷, ¾Ç¼ºº¯È¯À¸·Î ±¸ºÐµÈ´Ù. ¨ç¼º¼÷±âÇüÁ¾Àº ¿µ¾Æ±â¿Í ¾Æµ¿±â¿¡ ¸¹À¸¸ç Àß ºÐÈµÈ ¼¼Æ÷·Î ±¸¼ºµÇ´Â ¾ç¼º Á¾¾çÀÌ´Ù. ½Å°æ, ±ÙÀ°, ¿¬°ñ, »óÇÇ, °©»ó»ù, ±â°üÁö µî ¿©·¯ ¼¼Æ÷°¡ ¹ß°ßµÇ¸ç ¾Ç¼ºÀ¸·Î º¯ÈÇÒ ¼ö ÀÖ´Ù. ¨è¹Ì¼º¼÷±âÇüÁ¾Àº ¾î¸¥ÀÌ ¸¹À¸¸ç, Àß ºÐȵÇÁö ¾ÊÀº ¾Ç¼ºÁ¾¾çÀÌ´Ù. ±×·¯³ª ¾Ç¼ºÁ¾¾çÀÇ Æ¯¼ºÀ» ¸íÈ®ÇÏ°Ô º¸ÀÌÁö ¾Ê´Â °æ¿ì°¡ ÈçÇÏ´Ù. ¨é ¾Ç¼ºº¯È¯Àº ¾î¸¥¿¡ ¸¹À¸¸ç ¸í¹éÇÑ ¾Ç¼ºÁ¾¾çÀÇ ¼ºÁúÀ» º¸ÀÌ´Â ±âÇüÁ¾. |
||
| ¿µ¹® | renal biopsy | ÇÑ±Û | ÄáÆÏ»ý°Ë |
|---|---|---|---|
| ¼³¸í | ÄáÆÏÀÇ º´º¯ÀÌ ÀÇ½ÉµÉ ¶§ È®ÁøÀ» À§ÇØ ÁÖ»ç¹Ù´Ã µîÀ» ÀÌ¿ëÇÏ¿© ÄáÆÏÁ¶Á÷À» ÀϺΠ¶¼¾î³»¼ Çö¹Ì°æÀ¸·Î °Ë°æÇÏ´Â °Í. |
||
| ¿µ¹® | renal hypertension | ÇÑ±Û | ÄáÆÏ¼º°íÇ÷¾Ð |
|---|---|---|---|
| ¼³¸í | ÄáÆÏ½ÇÁúÀÇ º´º¯À¸·Î ÀÎÇØ ¾ß±âµÈ °íÇ÷¾Ð. ÄáÆÏÀÇ ´ëÇ¥Àû ±â´ÉÀº ³ëÆó¹° ¹× ¼öºÐÀÇ ¹è¼³ÀÌ´Ù. ±×·±µ¥ ÀÌ·¯ÇÑ ÄáÆÏ±â´É¿¡ ÀÌ»óÀÌ »ý°åÀ» °æ¿ì ü³»¿¡ °úÀ×¼öºÐÀÇ ÃàÀûÀÌ ¹ß»ýÇÏ°Ô µÈ´Ù. À̿Ͱ°Àº °úÀ×¼öºÐÀÇ ÃàÀûÀº Ç÷°ü³» Á¤¼ö¾ÐÀ» »ó½Â½ÃÄÑ °íÇ÷¾ÐÀ» À¯¹ßÇÏ°Ô µÈ´Ù. Ä¡·á´Â ¿øÀÎ ÄáÆÏº´ÀÇ ±³Á¤À̸ç ÀÌÀ¯¸¦ ¸ð¸£´Â ¿ø¹ß°íÇ÷¾Ð°ú ´Þ¸® ÄáÆÏ¼º°íÇ÷¾ÐÀÇ °æ¿ì¿¡´Â ¿øÀÎ ÄáÆÏº´ÀÌ ±³Á¤µÇ¸é °íÇ÷¾Ðµµ »ç¶óÁö°Ô µÈ´Ù. |
||
| ¿µ¹® | renal cell carcinoma | ÇÑ±Û | ÄáÆÏ¼¼Æ÷¾ÏÁ¾ |
|---|---|---|---|
| ¼³¸í | ÄáÆÏ¿¡ »ý±ä ¿ø½ÃÄáÆÏÁ¶Á÷¿¡¼ ¹ß»ýÇÑ ¾Ï. ÁÖ·Î ¿ø½Ã¼¼´¢°üÁ¶Á÷¿¡¼ ¹ß»ýÇÑ´Ù. ´ëÇ¥ÀûÀÎ ¼¼Æ÷Á¶Á÷ÇüÀº ¿°»ö½Ã ¼¼Æ÷ÁúÀÌ ¸¼°Ô ºñ¾îº¸ÀÌ´Â ¸¼Àº¼¼Æ÷¾ÏÁ¾ÀÌ´Ù. Ä¡·á´Â ¼ö¼ú°ú Ç×¾ÏÈÇпä¹ýÀÌ¸ç ¾ÆÁÖ µå¹°Áö¸¸ ÀúÀý·Î ³´´Â °æ¿ìµµ ÀÖ´Â °ÍÀ¸·Î º¸°íµÇ¾î ÀÖ´Ù. |
||
| ¿µ¹® | renal transplantation | ÇÑ±Û | ÄáÆÏÀÌ½Ä |
|---|---|---|---|
| ¼³¸í | ÄáÆÏº´À» °¡Áö°í ÀÖÀ¸³ª Ä¡·á°¡ ºÒ°¡´ÉÇÑ ¸¸¼ºÄáÆÏ±â´É»ó½Ç µîÀÇ Áúº´À» °¡Áø ȯÀÚÀÇ ½ÅÀåÀ» ¶¼¾î³»°í ȯÀÚ¿Í Ç׿ø¼ºÀÌ À¯»çÇÑ »ç¶÷ÀÇ ÄáÆÏÀ» À̽ÄÇØÁÖ´Â °Í. ÀÌ ¶§ ¼·Î°£ÀÇ Ç׿ø¼ºÀÇ À¯»çÁ¡ÀÌ ¸¹¾Æ¾ß °ÅºÎ¹ÝÀÀÀÌ ÀϾÁö ¾Ê´Â´Ù. ±×¸®°í ÀÏ´Ü ÄáÆÏÀ̽ÄÀ» ¹ÞÀº »ç¶÷Àº ¿À·£±â°£ µ¿¾È ¸é¿ª¾ïÁ¦Á¦¸¦ Åõ¿©ÇÏ¿© °ÅºÎ¹ÝÀÀÀ» ÁÙ¿©¾ß ÇÑ´Ù. ´ë°³ ÀÌ½ÄµÈ ÄáÆÏÀº ¾ûµ¢»À¿À¸ñ¿¡ À§Ä¡ÇÏ°Ô µÈ´Ù. |
||
| AFP | Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265] ; Oncofetal Antigens &nbs... |
|---|---|
| MT | magnetization transfer; malaria therapy; malignant teratoma; mammary tumor; mammilothalamic tract; m... |
| MTA | malignant teratoma, anaplastic; medical technical assistant; medical technology assessment; metatars... |
| MTI | malignant teratoma, intermediate; minimum time interval; moving target indicator |
| MTT | malignant teratoma, trophoblastic; maximal treadmill test; meal tolerance test; mean transit time; m... |
| ARI | 5--acute renal insufficiency |
|---|---|
| ARCD | Acquired renal cystic disease |
| ARF | Acute Renal Failure |
| ARN | Afferent renal nerves |
| BMRTC | Bone metastasising renal tumour of childhood |
| malignant teratoma | <oncology, tumour> A collection of cancerous cells which form cysts that contain one or more of the three primary embryonic germ layers: skin, hair or teeth. (27 Sep 1997) |
|---|---|
| sacrococcygeal teratoma | <tumour> Found in the region of the primitive pit and node. Most common tumour in the newborn period. Triphyllomatous teratoma, a teratoma composed of tissues derived from all three germ layers. Synonym: tridermoma. (05 Mar 2000) |
| ovarian teratoma | See: Ovary, dermoid cyst of the. (12 Dec 1998) |
| teratoma | <oncology, tumour> Malignant tumour (teratoma) thought to originate from primordial germ cells or misplaced blastomeres that contains tissues derived from all three embryonic layers, such as bone, muscle, cartilage, nerve, tooth buds and various glands. Accompanied by undifferentiated, pluripotent epithelial cells known as embryonal carcinoma cells. (16 Dec 1997) |
| teratoma orbitae | Unequal conjoined twins in which the parasite, usually very imperfectly developed, is attached at an orbit of the autosite. See: conjoined twins. Synonym: teratoma orbitae. Origin: L. Orbita, orbit, + G. Pagos, something fixed (05 Mar 2000) |
| teratoma, ovarian | Tumour that develops from a totipotential germ cell (a primary oocyte) retained within the egg sac (ovary). Being totipotential, that cell can give rise to all orders of cells necessary to form mature tissues and often recognizable structures such as hair, bone and sebaceous (oily) material, neural tissue and teeth. These tumours may occur at any age but the prime age of detection is in the childbearing years. The average age is 30. Up to 15% of women with ovarian teratomas have them in both ovaries. The tumours can range in size from a centimeter (less than a half inch) up to 45 cm (17 inches) in diameter. They can cause the ovary to twist (torsion) and imperil its blood supply. Although the large majority (about 98%) of ovarian teratomas are benign, the remaining fraction (about 2%) becomes malignant. The larger the ovarian teratoma, the greater the risk of rupture with spillage of the greasy contents which can create problems with adhesions, pain etc. Removal is usually the treatment of choice by laparotomy (surgery) or laparoscopy (with a scope). Ovarian teratomas are also called dermoid cysts of the ovary and referred to simply as dermoids. (12 Dec 1998) |
| acute renal failure | <nephrology> A sudden decline in renal function may be triggered by a number of acute disease processes. Examples include sepsis (infection), shock, trauma, kidney stones, kidney infection, drug toxicity (aspirin or lithium), poisons or toxins (drug abuse) or after injection with an iodinated contrast dye (adverse effect). Chronic renal failure represents a slow decline in kidney function over time. Chronic renal failure may be caused by a number of disorders which include long-standing hypertension, diabetes, congestive heart failure, lupus or sickle cell anaemia. Both forms of renal failure result in a life-threatening metabolic derangement. (27 Sep 1997) |
| aminoaciduria, renal | Impairment of renal tubular transport of amino acids. (12 Dec 1998) |
| back-pressure renal atrophy | <radiology> Caliectasis without obstruction, due to repeated episodes of obstruction, gradual loss of renal pyramids (12 Dec 1998) |
| base of renal pyramid | The outer broad part of a renal pyramid that lies next to the cortex. Synonym: basis pyramidis renis. (05 Mar 2000) |
| branchio-oto-renal syndrome | <syndrome> An autosomal dominant disorder manifested by various combinations of preauricular pits, branchial fistulae or cysts, lacrimal duct stenosis, hearing loss, structural defects of the outer, middle, or inner ear, and renal dysplasia. Associated defects include asthenic habitus, long narrow facies, constricted palate, deep overbite, and myopia. Hearing loss may be due to mondini type cochlear defect and stapes fixation. (12 Dec 1998) |
| capsular branches of renal artery | <anatomy, artery> Branches arising from the renal artery outside of the kidney that are distributed to the renal capsule. Synonym: rami capsulares arteriae renalis. (05 Mar 2000) |
| captopril renal scan | <radiology> In a kidney with a lesion in the afferent arteriole (e.g. Atherosclerotic plaque), reflex constriction of the efferent arteriole occurs through angiotensin system thus maintaining renal perfusion. ACE inhibition prevents constriction of efferent arteriole. Therefore, perfusion is decreased to a kidney with afferent lesions and the renal scan to looks WORSE. Bottom line: renal scans appear WORSE with captopril administration if there is a lesion in the afferent arteriole. See: renal artery stenosis (12 Dec 1998) |
| carcinoma, renal cell | Carcinoma of the renal parenchyma usually occurring in middle age or later and composed of tubular cells in varying arrangements. It was first described in 1826. Possible causal factors are environmental, hormonal, cellular, and genetic. Smoking is a definite risk factor and obesity is associated with increased risk. Renal cell carcinoma accounts for approximately 3% of adult cancer; the male-female ratio is 2:1. It is more common among urban residents than rural. (12 Dec 1998) |
| renal | <anatomy> Pertaining to the kidney, nephric. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|